Skip to main content

November 2016

academics

 

Clinical research courses

Pfizer Inc. announced the discontinuation of the global clinical development programmeme for bococizumab, its investigational Proprotein Convertase Subtilisin Kexin type 9 inhibitor (PCSK9i). The totality of clinical information now available for bococizumab, taken together with the evolving treatment and market landscape for lipid-lowering agents, indicates that bococizumab is not likely to provide value to patients, physicians, or shareholders. As a result, Pfizer has decided to discontinue the development programme, including the two ongoing cardiovascular outcome studies.

Allergan plc, a leading global pharmaceutical company, announced that it has successfully completed the acquisition of Tobira Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for non-alcoholic steatohepatitis (NASH) and other liver diseases.

GVK BIO looking for Executive / Sr. Executive - walk in | Only experience candidate

GVK BIO is perfectly suited to meet the demands of the constantly-evolving Pharma and Biotech industries. Currently, we provide holistic services to nearly 200 companies, offering specialized services to each. Our Collaborative Research capabilities present no conflict, as we offer multiple business models. By integrating large scale manufacturing, we are equipped to transfer technology seamlessly. Our sourcing capabilities are designed to meet cost and time constraints of our clients. Strong IP and Confidentiality measures instill confidence in them. All these factors combined, make the products and services offered by GVK BIO truly one-of-a-kind.

 Post : Executive / Sr. Executive

Job for Scientific Writer II in Novartis

A global healthcare leader, Novartis has one of the most   exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Scientific Writer II

Walk in interview for fresh B.Pharm / M.Pharm as Medical Coding Trainee at Gebbs Healthcare | 150 posts

GeBBS is a leading provider of healthcare Business Process Outsourcing services to Healthcare Providers (Medical Billing companies, Hospitals, Faculty Practices, ASC’s, LTC’s, etc.) and Pharmacies. We help our clients succeed by leveraging on our domain expertise and technology platforms along with our cost effective approach to global outsourcing.

Post: Medical Coding Trainee- 150 posts

Vacancy for Medical Officer at AnaCipher Clinical Research Organization

AnaCipher Clinical Research Organization, a division of Indoco Remedies Ltd. is a Contract Research Organization specialized in bioequivalence and analytical studies. The state-of-the-art facility is spread over an area of 30,000 sq. ft. at Hyderabad, India, with capabilities to conduct bioavailability and bioequivalence studies, bioanalytical method development and validation, sample processing and analysis, statistical analysis and reporting.

Post : Medical Officer - 02 posts

Walk in Interview in Production, QC at Macleods

Macleods, India’s fastest growing pharmaceutical company, with manufacturing sites approved by USFOA & WHO Geneva, ranked among the top pharmaceutical companies with strength of 10,000 employees, operating 60 countries worldwide, required talented professionals for Formulation Plant at Baddi (HP), Sikkim & Sarlgam.

Work as Quality Analyst at AnaCipher Clinical Research Organization

AnaCipher Clinical Research Organization, a division of Indoco Remedies Ltd. is a Contract Research Organization specialized in bioequivalence and analytical studies. The state-of-the-art facility is spread over an area of 30,000 sq. ft. at Hyderabad, India, with capabilities to conduct bioavailability and bioequivalence studies, bioanalytical method development and validation, sample processing and analysis, statistical analysis and reporting.

Post : Quality Analyst

Walk-in for B.Pharm/M.Pharm/M.Sc at Medreich -Only experienced | AR&D - FR&D

Medreich facilities have received the seal of approval from leading global regulatory bodies such as -UK MHRA, Australia TGA, SA MCC, Health Canada, and French AFSSAP, GCC, PIC, regulatory bodies of various countries in the African continent and independent bodies like UNICEF and MSF.